Alembic Pharmaceuticals has reported results for third quarter ended December 31, 2011.
The company has posted a rise of 15% in its net sales at Rs 383 crore for the quarter ended December 31, 2011 as compared to Rs 332 crore in corresponding quarter last year. The profit before tax was up by 18% at Rs 53.54 crore for the quarter under review as compared to Rs 45.40 crore in corresponding quarter last year.
Domestic formulations were up 8% at Rs 199 crore against Rs 184 crore in corresponding quarter last year. International generics were up by 13% to Rs 58 crore compared to Rs 52 crore last year.
The company has received approval for 2 ANDA in current quarter while 3 DMF’s were filed during the quarter.
